Cancer is not a risk factor for severe COVID‐19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

• Published in: Pediatric blood & cancer Vol. 71; no. 8; pp. e31120 - n/a
• Main Authors: Velasco Puyó, Pablo, Tagarro, Alfredo, Garcia‐Obregon, Susana, Villate, Olatz, Moraleda, Cinta, Huerta Aragonés, Jorge, Bardón Cancho, Eduardo J., Faura Morros, Anna, Galán‐Gómez, Víctor, Escobar Fernández, Laura, Lendinez‐Molinos, Francisco, Herrero Velasco, Blanca, Ureña Horno, Laura, Domínguez‐Pinilla, Nerea, Pascual Gazquez, Juan Francisco, Nova Lozano, Cristina, Osuna‐Marco, Marta, Marín‐Cruz, Inés, Gomez Pastrana, Irene, Garcia de Andoin Barandiaran, Nagore, Gallego Mingo, Nerea, Portugal Rodríguez, Raquel, Cañete, Adela, Pareja León, Marta, Castrillo Bustamante, Sara, Tallón García, María, Gónzalez‐Prieto, Almudena, Solé‐Rodríguez, María, González Cruz, Macarena, Soriano‐Arandes, Antonio, Mota, Miriam, Pérez‐Hoyos, Santiago, Moreno, Lucas, Astigarraga, Itziar
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.08.2024
• Subjects: allogenic HSCT; Allografts; Cancer; Children; comorbidities; Comorbidity; COVID-19; Hematopoietic stem cells; Pediatrics; Registry; Risk factors; Severe acute respiratory syndrome coronavirus 2; Stem cell transplantation; cancer; Registry; allogenic HSCT; COVID‐19; comorbidities; children
• ISSN: 1545-5009; 1545-5017; 1545-5017
• DOI: 10.1002/pbc.31120

The EPICO (Spanish general registry of COVID‐19 in children)‐SEHOP (Spanish Society of Pediatric Hematology and Oncology) platform gathers data from children with SARS‐CoV‐2 in Spain, allowing comparison between children with cancer or allogeneic hematopoietic stem cell transplantation (alloHSCT) and those without. The infection is milder in the cancer/alloHSCT group than in children without comorbidities (7.1% vs. 14.7%), except in children with recent alloHSCT (less than 300 days), of which 35.7% experienced severe COVID‐19. These data have been shared with the SEHOP members to support treatment and isolation policies akin to those for children without cancer, except for those with recent alloHSCT or additional comorbidities. This highlights the collaborative registries potential in managing pandemic emergencies.